GlycoMimetics
GLYC
#10327
Rank
ยฃ7.6 M
Marketcap
ยฃ0.12
Share price
-5.42%
Change (1 day)
-48.15%
Change (1 year)

GlycoMimetics (GLYC) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : ยฃ1.96 Million

According to GlycoMimetics 's latest financial reports the company's total liabilities are ยฃ1.96 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

GlycoMimetics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ4.6 M-15.01%
2023-12-31ยฃ5.41 M-26.2%
2022-12-31ยฃ7.34 M-22.24%
2021-12-31ยฃ9.44 M-11.94%
2020-12-31ยฃ10.72 M2.1%
2019-12-31ยฃ10.5 M42.18%
2018-12-31ยฃ7.38 M12.38%
2017-12-31ยฃ6.57 M14.42%
2016-12-31ยฃ5.74 M6.52%
2015-12-31ยฃ5.39 M29.94%
2014-12-31ยฃ4.14 M188.08%
2013-12-31ยฃ1.44 M-60.48%
2012-12-31ยฃ3.64 M-72.3%
2011-12-31ยฃ13.15 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
bluebird bio
BLUE
ยฃ0.26 B 13,420.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ86.80 B 4,418,627.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ49.56 B 2,522,974.75%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
ยฃ85.22 B 4,338,533.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
ยฃ7.59 M 286.54%๐Ÿ‡บ๐Ÿ‡ธ USA